MedTrace Logo

Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

NCT05614128 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2025-06-05

No results posted yet for this study

Summary

The goal of this observational study is to learn about chronic inflammatory demyelinating polyneuropathy. The main question the investigators would like to answer is 1) can skin biopsy identify demyelination better than nerve conduction studies (electrical tests of the nerves)? and 2) how do nerves improve after treatment in CIDP? Participants will be asked to undergo skin biopsy of the finger at baseline and at 3 months and 6 months after treatment with IVIG (which is the FDA approved treatment for CIDP).

Conditions

Interventions

OTHER

IVIg

Patients will be treated with IVIg as recommended by expert guidelines for treatment of CIDP under care of their primary neurologist. This will not be provided by the study.

Sponsors & Collaborators

  • CSL Behring

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Wende Fedder, Rn · Vanderbilt University Medical Center

  • Diana Davis, RN · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2024-09-19
Completion
2024-09-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05614128 on ClinicalTrials.gov